Press Releases

Mar 27, 2026

Leila Farooq

Press Releases

One and One Green Technologies. INC Launches Luzon Copper-Gold Ore Tailings Slag Venture to Address Projected 150,000-Ton Global Copper Supply Deficit

One and One Green Technologies. INC (NASDAQ: YDDL), a licensed hazardous waste recycler in the Philippines, announced a new business venture to recover copper-gold ore tailings slag in Luzon. This strategic initiative targets the projected global copper supply deficit of 150,000 metric tons in 2026 by partnering with local small-scale miners and le…

YDDL

Mar 27, 2026

Ajmal Hussain

Press Releases

ORIC® Pharmaceuticals to Report Combination Dose Optimization Data From Phase 1b Trial of Rinzimetostat in Patients with mCRPC

ORIC Pharmaceuticals announced plans to report combination dose optimization data from its Phase 1b trial of rinzimetostat in metastatic castration resistant prostate cancer patients. The presentation will occur during a webcast and conference call on March 31, 2026. This update provides insights into dosing strategies for an investigational allost…

ORIC

Mar 27, 2026

Derek Hwang

Press Releases

BranchOut Food Inc. Announces Fourth Quarter and Full Year 2025 Earnings Call and Shareholder Update

BranchOut Food Inc., a food technology company specializing in natural fruit and vegetable snacks using its proprietary GentleDry process, announced a conference call to discuss its Q4 and full-year 2025 financial results along with a corporate and shareholder update scheduled for March 31, 2026. The company highlighted its patented dehydration tec…

BOF

Mar 27, 2026

Derek Hwang

Press Releases

Ocean Power Technologies Secures Order for Fully Integrated WAM-V for an Underwater Research Customer in the Nordics

Ocean Power Technologies announced securing a contract to deliver a fully integrated WAM-V autonomous surface vehicle to a new underwater research customer in the Nordics. This order marks an expansion of the company's presence in the Nordic region and demonstrates ongoing demand across multiple sectors including defense, surface inspections, and u…

OPTT

Mar 27, 2026

Ajmal Hussain

Press Releases

Cyabra Announces Completion of Business Combination with Trailblazer Merger Corp.

Cyabra, a company dedicated to identifying coordinated manipulation in online narratives and protecting digital trust, has completed its business combination with Trailblazer Merger Corp. Cyabra's common stock is set to begin trading on Nasdaq on March 27, 2026, under the ticker CYAB. The combination supports Cyabra's mission to combat disinformati…

CYAB

Mar 27, 2026

Maya Rios

Press Releases

Quantum Biopharma’s 2025 Audited Year End Financial Results Maintain ‘No Going Concern’ Status

Quantum BioPharma Ltd. announced its audited financial results for 2025 showing a strong balance sheet with $11.3 million in cash and digital assets, improved working capital, and reduced operating expenses. The company completed Phase 1 toxicology studies for its oral MS drug candidate Lucid-MS, advancing toward Phase 2 trials. Additionally, clini…

QNTM

Mar 27, 2026

Avery Klein

Press Releases

Inflection Point Acquisition Corp. VI Announces Pricing of $220 Million Initial Public Offering

Inflection Point Acquisition Corp. VI, a special purpose acquisition company (SPAC), announced the pricing of its IPO, offering 22 million units at $10 each, expected to raise $220 million. The units will trade on Nasdaq under ticker IPFXU, with separate trading expected for shares and warrants under IPFX and IPFXW respectively. The company aims to…

IPFXU

Mar 27, 2026

Derek Hwang

Press Releases

Hydrofarm Holdings Group Announces Fourth Quarter and Full Year 2025 Results

Hydrofarm Holdings Group, Inc. announced its fourth quarter and full year 2025 financial results showing a 32.7% reduction in net sales for Q4 compared to the prior year, driven by industry oversupply and price decreases. Despite improvements in gross profit margins and reduced operating expenses due to restructuring efforts, the company reported a…

HYFM

Mar 27, 2026

Nina Shah

Press Releases

Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones

Glucotrack, Inc. announced significant progress towards filing an Investigational Device Exemption (IDE) with the U.S. FDA in Q2 2026 to initiate a U.S. clinical trial for its implantable continuous blood glucose monitoring system. Following successful first-in-human trials in Brazil and a follow-up study in Australia, the company completed key tri…

GCTK

Mar 27, 2026

Hana Yamamoto

Press Releases

Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

Senti Biosciences announced its fourth quarter and full year 2025 financial results, marking significant progress in its clinical pipeline, particularly with SENTI-202 for relapsed/refractory acute myeloid leukemia (AML). The company reported positive preliminary Phase 1 clinical data, received FDA Regenerative Medicine Advanced Therapy designation…

SNTI

Mar 27, 2026

Maya Rios

Press Releases

Norwegian Cruise Line Holdings Enters into Employment and Equity Award Agreements with President and CEO

Norwegian Cruise Line Holdings Ltd. announced the appointment of John W. Chidsey as President and CEO, effective February 2026, accompanied by a new employment agreement and a $48 million restricted share unit award designed to incentivize long-term shareholder value creation over four years. The equity award includes performance-based and time-ves…

NCLH

Mar 27, 2026

Nina Shah

Press Releases

Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone

Profound Medical Corp. announced that Texas Prostate, led by Dr. James Cochran, has reached the milestone of performing 100 TULSA Procedures using Profound's TULSA-PRO system at Dallas Medical Center. The collaboration has increased procedure volume by 500% since transitioning to a Medicare payment model, accelerating adoption of this innovative, M…

PROF

Mar 27, 2026

Derek Hwang

Press Releases

Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

Clearmind Medicine Inc., a Nasdaq-listed clinical-stage biotech company, announced the filing of a patent application in India for next-generation psychedelic compounds aimed at treating mental health disorders and addiction. This move expands the company's global intellectual property portfolio and builds on its licensing agreement with Yissum Res…

CMND

Mar 27, 2026

Avery Klein

Press Releases

Streamex Corp. Clarifies and Refutes Inaccurate Claims Regarding Lock-Up Agreements; Co-Founders Morgan Lekstrom & Henry McPhie Enter into Voluntary 1 Year Lock-Up Agreements

Streamex Corp. clarifies and disproves misleading third-party reports about the expiration of lock-up agreements related to its January 2026 financing. The company confirms that the previous lock-ups of certain shares held by co-founders Henry McPhie and Morgan Lekstrom were shorter than reported and that newly agreed voluntary one-year lock-ups ha…

STEX

Mar 27, 2026

Jordan Park

Press Releases

Sportradar Files Its Annual Report on Form 20-F

Sportradar Group AG, a leading global sports technology company, announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the SEC. The report is available to investors via the company’s website and SEC filings. Sportradar provides technology and services to sports federations, media, and betting opera…

SRAD

Mar 27, 2026

Sofia Navarro

Press Releases

SFL - Notice of Annual General Meeting 2026

SFL Corporation Ltd., a maritime shipping company listed on the NYSE, announced its Annual General Meeting to be held on May 11, 2026, with voting record date set for April 1, 2026. The company highlighted its stable dividend record since 2004 and provided a cautionary statement about risks and uncertainties affecting its business including market …

SFL

Mar 27, 2026

Priya Menon

Press Releases

ParaZero Issues CEO Letter to Shareholders: Reports Strong Revenue Growth for Full Year 2025

ParaZero Technologies Ltd. announced a successful transformation in 2025 from a drone safety components supplier to a leading Tier 1 defense provider specializing in multi-layered autonomous counter-unmanned aerial systems (C-UAS). The company reported a 12% year-over-year revenue growth in 2025, with early 2026 orders already exceeding the full pr…

PRZO

Mar 27, 2026

Caleb Monroe

Press Releases

Aurora Mobile Partners with Soochow Securities to Advance Digital Transformation and Develop Intelligent Financial Services Platform

Aurora Mobile has entered into a strategic partnership with Soochow Securities to integrate its intelligent push notification platform, JPush, into Soochow Securities' 'Dongwu Xiucai' mobile app. This collaboration aims to improve real-time, secure delivery of financial notifications and personalized client communication, advancing Soochow's digita…

JG

Mar 27, 2026

Ajmal Hussain

Press Releases

Satellos Reports 2025 Financial Results and Highlights Recent Company Progress

Satellos Bioscience Inc. reported significant progress in 2025, including closing a $57.2 million equity financing, commencing Nasdaq trading under ticker MSLE, and initiating two Phase 2 clinical trials (BASECAMP and TRAILHEAD) for its lead candidate SAT-3247 targeting Duchenne muscular dystrophy (DMD). Clinical data showed maintained or improved …

MSLE

Mar 27, 2026

Hana Yamamoto

Press Releases

Legence Reports Fourth Quarter and Year End 2025 Financial Results

Legence Corp. reported record quarterly revenues of $737.6 million for Q4 2025, a 34.6% increase year-over-year, driven mainly by organic growth. The company posted a 53% increase in quarterly Adjusted EBITDA and a 49% increase in total backlog and awarded contracts to $3.7 billion. Strategic acquisitions including Bowers and Metrix enhance its mar…

LGN

Mar 27, 2026

Ajmal Hussain

Press Releases

Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Autolus Therapeutics reported fourth quarter and full year 2025 financial results highlighted by $74.3 million in net product revenue for their CAR T cell therapy AUCATZYL, approved for relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL). The company has launched AUCATZYL in the UK following positive NICE evaluation and expects conti…

AUTL

Mar 27, 2026

Caleb Monroe

Press Releases

DoubleDown Interactive Announces Results of 2026 Annual General Meeting

DoubleDown Interactive Co., Ltd., a developer and publisher of digital games, announced the results of its 2026 Annual General Meeting. Shareholders approved the 18th financial statements for 2025, elected two independent directors, approved amendments to the Articles of Incorporation, and set remuneration limits for independent directors and execu…

DDI

Mar 27, 2026

Priya Menon

Press Releases

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates

Werewolf Therapeutics announced its Q4 and full-year 2025 financial results, highlighting a reduced net loss and operational expenses compared to 2024. The company revealed its decision to explore strategic alternatives, including potential sale, merger, or collaborations to maximize shareholder value. With $57.1 million in cash at year-end, they e…

HOWL

Mar 27, 2026

Hana Yamamoto

Press Releases

Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

Humacyte, Inc. announced its financial results for Q4 and full year 2025 with revenues of $0.5 million and $2.0 million respectively, driven by the commercial launch of Symvess in the US and strategic international expansion efforts. The company secured a $1.475 million purchase commitment from Saudi Arabia for clinical evaluation and is pursuing r…

HUMA

Mar 27, 2026

Leila Farooq

Press Releases

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

Radiopharm Theranostics has dosed the first patient in its Phase 1 clinical trial of RAD 402, a monoclonal antibody radiolabeled with Terbium-161, targeting KLK3 for advanced prostate cancer. The trial aims to assess safety, tolerability, biodistribution, and preliminary efficacy, with data from initial dose levels expected by mid-2026. Preclinical…

RAD